The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

By
February 24, 2026
4 min

Fox Chase Cancer Center

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Fox Chase Cancer Center

Philadelphia, PA
Key Differentiators
- Cancer Genomics
- Epigenetics
- Hematologic Oncology
- Sarcoma Oncology
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Cancer Genomics
- Hematologic Malignancies
- Sarcoma Treatment
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Cancer Genomics
- Hematology/Oncology
- Sarcoma Research
#4

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Cancer Genomics
- Hematologic Oncology
- Sarcoma Treatment

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Top Institutions in Oncology

Fox Chase Cancer Center

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

MD Anderson Cancer Center

Original Source(s)

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Related Content

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

High-grade astrocytoma with piloid features: a case report of comprehensive management

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort